Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using eLISA

Kiyoshi Noda, Kuniaki Tanaka, Akira Yamada, Jyunko Ogata, Hiroyuki Tanaka, Yukihiro Shoyama

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A quantitative ELISA system was developed using a monoclonal antibody (MAb) specific for an antitumour immunoactive glycoprotein (CVS) derived from C. vulgaris strain CK22. The full measuring range of the assay extends from 0.63 to 10.0 ng/mL of CVS. Although no cross-reaction was observed to proteins tested or other biological response modifiers (BRMs) derived from different sources, cross-reactions were found with culture supernatants from two other strains of C. vulgaris having a strong antitumour immunoactivity. Treatment of CVS with protease, acid or alkali weakened or completely eliminated the reactivity against the MAb and also its antitumour immunoactivities. This ELISA system is suitable for the biologically active form of CVS derived from C. vulgaris strain CK22 and related immunoactive strains.

Original languageEnglish
Pages (from-to)581-585
Number of pages5
JournalPhytotherapy Research
Volume16
Issue number6
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Chlorella vulgaris
Glycoproteins
Cross Reactions
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Immunologic Factors
Alkalies
Peptide Hydrolases
Acids
Proteins
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using eLISA. / Noda, Kiyoshi; Tanaka, Kuniaki; Yamada, Akira; Ogata, Jyunko; Tanaka, Hiroyuki; Shoyama, Yukihiro.

In: Phytotherapy Research, Vol. 16, No. 6, 01.01.2002, p. 581-585.

Research output: Contribution to journalArticle

Noda, Kiyoshi ; Tanaka, Kuniaki ; Yamada, Akira ; Ogata, Jyunko ; Tanaka, Hiroyuki ; Shoyama, Yukihiro. / Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using eLISA. In: Phytotherapy Research. 2002 ; Vol. 16, No. 6. pp. 581-585.
@article{02b4114e2a5a4018922dc66e9e265505,
title = "Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using eLISA",
abstract = "A quantitative ELISA system was developed using a monoclonal antibody (MAb) specific for an antitumour immunoactive glycoprotein (CVS) derived from C. vulgaris strain CK22. The full measuring range of the assay extends from 0.63 to 10.0 ng/mL of CVS. Although no cross-reaction was observed to proteins tested or other biological response modifiers (BRMs) derived from different sources, cross-reactions were found with culture supernatants from two other strains of C. vulgaris having a strong antitumour immunoactivity. Treatment of CVS with protease, acid or alkali weakened or completely eliminated the reactivity against the MAb and also its antitumour immunoactivities. This ELISA system is suitable for the biologically active form of CVS derived from C. vulgaris strain CK22 and related immunoactive strains.",
author = "Kiyoshi Noda and Kuniaki Tanaka and Akira Yamada and Jyunko Ogata and Hiroyuki Tanaka and Yukihiro Shoyama",
year = "2002",
month = "1",
day = "1",
doi = "10.1002/ptr.1021",
language = "English",
volume = "16",
pages = "581--585",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Simple assay for antitumour immunoactive glycoprotein derived from Chlorella vulgaris strain CK22 using eLISA

AU - Noda, Kiyoshi

AU - Tanaka, Kuniaki

AU - Yamada, Akira

AU - Ogata, Jyunko

AU - Tanaka, Hiroyuki

AU - Shoyama, Yukihiro

PY - 2002/1/1

Y1 - 2002/1/1

N2 - A quantitative ELISA system was developed using a monoclonal antibody (MAb) specific for an antitumour immunoactive glycoprotein (CVS) derived from C. vulgaris strain CK22. The full measuring range of the assay extends from 0.63 to 10.0 ng/mL of CVS. Although no cross-reaction was observed to proteins tested or other biological response modifiers (BRMs) derived from different sources, cross-reactions were found with culture supernatants from two other strains of C. vulgaris having a strong antitumour immunoactivity. Treatment of CVS with protease, acid or alkali weakened or completely eliminated the reactivity against the MAb and also its antitumour immunoactivities. This ELISA system is suitable for the biologically active form of CVS derived from C. vulgaris strain CK22 and related immunoactive strains.

AB - A quantitative ELISA system was developed using a monoclonal antibody (MAb) specific for an antitumour immunoactive glycoprotein (CVS) derived from C. vulgaris strain CK22. The full measuring range of the assay extends from 0.63 to 10.0 ng/mL of CVS. Although no cross-reaction was observed to proteins tested or other biological response modifiers (BRMs) derived from different sources, cross-reactions were found with culture supernatants from two other strains of C. vulgaris having a strong antitumour immunoactivity. Treatment of CVS with protease, acid or alkali weakened or completely eliminated the reactivity against the MAb and also its antitumour immunoactivities. This ELISA system is suitable for the biologically active form of CVS derived from C. vulgaris strain CK22 and related immunoactive strains.

UR - http://www.scopus.com/inward/record.url?scp=0036741522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036741522&partnerID=8YFLogxK

U2 - 10.1002/ptr.1021

DO - 10.1002/ptr.1021

M3 - Article

VL - 16

SP - 581

EP - 585

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 6

ER -